PacBio’s revenues from the Americas were $33.9 million, up 182% year over year. The uptick was driven by continued growth in instruments and consumables from both new and existing customers.

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent 2024 preliminary results and restructuring ...

Gene sequencing specialist PacBio has reached an agreement to buy Apton Biosystems, boosting its position in short-read sequencing technology that has traditionally been dominated by rival Illumina.

MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David ...

(RTTNews) - PacBio (PACB), Tuesday announced preliminary revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154.0 million representing a year-over-year decline of 33% ...

PacBio (PACB) announced the appointment of Chris Smith to its Board of Directors, effective today. Smith is currently the Chief Executive Officer of NeoGenomics (NEO). Published first on TheFly ...

MENLO PARK, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, has delivered its first Vega systems to Berry ...

The company is known for pioneering DNA sequencing. Chris Smith, CEO of oncology diagnostic company NeoGenomics Inc., is getting a seat on the board of Pacific Biosciences of California Inc ...

Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight Cathie Wood is investing in PacBio, a biotech company with potential for genomics revolution. ARK Invest ...

MENLO PARK, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leader in high-quality, long-read sequencing, is proud to announce its critical role in a study to be published in Nature ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent 2024 preliminary results and ...